Management of Metastatic Colorectal Cancer: A Clinical and Patient Perspective

Servier Affaires Médicales738 enrolled

Overview

A Real World Evidence Prospective Cohort Study in the Management of Metastatic Colorectal Cancer: A Clinical and Patient Perspective

Study Type

OBSERVATIONAL

Enrollment

738

Conditions

Metastatic Colorectal Cancer

Interventions

observational disease studyOTHER

observation of routine clinical practices in mCRC

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age ≥ 18 * Diagnosis of mCRC * Having had two disease progressions since diagnosis of first metastasis that led to first systemic treatment. Exclusion Criteria: * Currently participating in an investigational clinical trial (thus it does not apply to observational cohort studies) * Currently being treated for other cancer(s) * Not having mental capacity and/or ability to participate in the study

Locations (18)

Instituto de Oncología Angel H. Roffo

Buenos Aires, Argentina

Landeskrankenhaus-Universitaetsklinik

Salzburg, Austria

Outcomes

Primary Outcomes

Overall survival

metastatic Colorectal Cancer (mCRC) overall survival in real world setting

Time frame: From date of randomization until the date of death from any cause, assessed up to 24 months months

Secondary Outcomes

Disease control measured by overall response

Overall response to treatment defined by complete and partial response, stable disease, progression of the disease

Time frame: within 18 months from enrollment

Quality of life using Patients Reported Outcomes

Patients Reported Outcomes defined by a modified version of the questionnaire ACCEPTance by the Patients of their Treatment (ACCEPT)

Time frame: within 18 months from enrollment

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.